Predictive value of (18)F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy.

Başoğlu, Tuğba; Özgüven, SALİH; Özkan, Hülya; Çınar, Merve; Köstek, OSMAN; Demircan, Nazım; Arıkan, Rukiye; Telli, Tuğba; Ercelep, Özlem; Kaya, Handan; Öneş, Tunç; Erdil, Tanju; Uğurlu, MUSTAFA; Dane, Faysal; Yumuk, Perran

doi:10.1016/j.remnie.2021.05.007

Predictive value of (18)F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy.

Başoğlu T., Özgüven S., Özkan H. Ş., Çınar M., Köstek O., Demircan N. C., ...Daha Fazla

Revista espanola de medicina nuclear e imagen molecular, cilt.41, sa.3, ss.171-178, 2022 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 41 Sayı: 3
Basım Tarihi: 2022
Doi Numarası: 10.1016/j.remnie.2021.05.007
Dergi Adı: Revista espanola de medicina nuclear e imagen molecular
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
Sayfa Sayıları: ss.171-178
Anahtar Kelimeler: Breast neoplasms, Drug therapy, Residual cancer burden, Metabolic tumor volume, Total lesion glycolysis, Positron emission tomography computed tomography, PATHOLOGICAL COMPLETE RESPONSE, FDG-PET/CT
Marmara Üniversitesi Adresli: Evet

Özet

Aim: We investigated the correlation between F-18-FDG PET/CT indices and pathological response in breast cancer treated with neoadjuvant chemotherapy (NACT) which was scored with Residual Cancer Burden (RCB) system after surgery. Our aim is to detect extensive residual cancer burden earlier by using PET/CT indices.